Enrico Giuseppe Ferro, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Appendage | 3 | 2023 | 283 | 0.980 |
Why?
|
Atrial Fibrillation | 5 | 2024 | 5127 | 0.810 |
Why?
|
Pericardial Effusion | 1 | 2023 | 247 | 0.760 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 807 | 0.570 |
Why?
|
Troponin | 1 | 2020 | 502 | 0.560 |
Why?
|
Medicare | 8 | 2024 | 6770 | 0.550 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15502 | 0.510 |
Why?
|
Patient Readmission | 3 | 2019 | 3271 | 0.500 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 3085 | 0.450 |
Why?
|
Hypertension | 3 | 2023 | 8540 | 0.450 |
Why?
|
Cost Savings | 1 | 2019 | 913 | 0.440 |
Why?
|
Triage | 1 | 2020 | 986 | 0.440 |
Why?
|
Defibrillators, Implantable | 1 | 2023 | 1490 | 0.440 |
Why?
|
Language | 1 | 2022 | 1543 | 0.420 |
Why?
|
Homosexuality, Male | 3 | 2017 | 1334 | 0.410 |
Why?
|
Outpatients | 1 | 2020 | 1597 | 0.410 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 2751 | 0.370 |
Why?
|
Catheter Ablation | 1 | 2024 | 2751 | 0.360 |
Why?
|
South Africa | 3 | 2023 | 1843 | 0.310 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 2190 | 0.290 |
Why?
|
Insurance Coverage | 1 | 2019 | 1940 | 0.290 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2021 | 12149 | 0.290 |
Why?
|
Medicaid | 1 | 2019 | 2818 | 0.250 |
Why?
|
Patient Compliance | 1 | 2014 | 2690 | 0.230 |
Why?
|
Alcoholism | 1 | 2014 | 1973 | 0.220 |
Why?
|
Hospitalization | 2 | 2024 | 10721 | 0.220 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7879 | 0.180 |
Why?
|
Hirudins | 2 | 2017 | 179 | 0.170 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4527 | 0.150 |
Why?
|
Pulmonary Veins | 1 | 2024 | 743 | 0.150 |
Why?
|
Heart Failure | 2 | 2021 | 11671 | 0.150 |
Why?
|
Masks | 1 | 2020 | 208 | 0.150 |
Why?
|
United States | 10 | 2024 | 72340 | 0.150 |
Why?
|
Humans | 26 | 2024 | 761596 | 0.140 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1086 | 0.140 |
Why?
|
Antithrombins | 2 | 2017 | 294 | 0.140 |
Why?
|
Aged | 13 | 2024 | 169310 | 0.140 |
Why?
|
HIV Infections | 4 | 2017 | 17354 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 851 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
Peptide Fragments | 2 | 2017 | 5112 | 0.120 |
Why?
|
Keratoacanthoma | 1 | 2014 | 33 | 0.110 |
Why?
|
Thrombectomy | 1 | 2019 | 705 | 0.110 |
Why?
|
Anticoagulants | 2 | 2021 | 4812 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 415 | 0.110 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 638 | 0.110 |
Why?
|
Warfarin | 1 | 2021 | 1483 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.110 |
Why?
|
Hospital Costs | 1 | 2019 | 947 | 0.100 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.100 |
Why?
|
Prisoners | 1 | 2016 | 314 | 0.100 |
Why?
|
Heart-Assist Devices | 1 | 2023 | 1287 | 0.100 |
Why?
|
Comorbidity | 2 | 2024 | 10508 | 0.100 |
Why?
|
Hair Follicle | 1 | 2014 | 211 | 0.100 |
Why?
|
Stroke | 3 | 2023 | 9758 | 0.090 |
Why?
|
Tretinoin | 1 | 2014 | 519 | 0.090 |
Why?
|
Prevalence | 3 | 2023 | 15733 | 0.090 |
Why?
|
Blood Pressure | 2 | 2023 | 8481 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2495 | 0.090 |
Why?
|
Male | 13 | 2024 | 360846 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2023 | 80647 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2321 | 0.080 |
Why?
|
Hospitals | 2 | 2020 | 3883 | 0.080 |
Why?
|
Heparin | 1 | 2016 | 1634 | 0.080 |
Why?
|
Echocardiography | 1 | 2021 | 4989 | 0.080 |
Why?
|
Risk Factors | 5 | 2023 | 74213 | 0.080 |
Why?
|
Electrocardiography | 1 | 2021 | 6377 | 0.080 |
Why?
|
Female | 12 | 2024 | 392705 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3627 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58984 | 0.070 |
Why?
|
Incidence | 2 | 2023 | 21355 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3335 | 0.070 |
Why?
|
Inpatients | 1 | 2017 | 2548 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20100 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7054 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26129 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7968 | 0.050 |
Why?
|
Tuberculosis | 1 | 2016 | 2017 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2024 | 64685 | 0.050 |
Why?
|
Peru | 2 | 2017 | 891 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11461 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15633 | 0.050 |
Why?
|
Stem Cells | 1 | 2014 | 3524 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4420 | 0.040 |
Why?
|
Hospital Mortality | 3 | 2019 | 5293 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4024 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2023 | 709 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.040 |
Why?
|
Registries | 3 | 2019 | 8225 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2017 | 6534 | 0.040 |
Why?
|
Telemedicine | 1 | 2014 | 3052 | 0.030 |
Why?
|
Asia, Southeastern | 1 | 2016 | 114 | 0.030 |
Why?
|
Malaysia | 1 | 2016 | 107 | 0.030 |
Why?
|
Criminal Law | 1 | 2016 | 97 | 0.030 |
Why?
|
Drug Utilization Review | 1 | 2016 | 248 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5821 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 999 | 0.030 |
Why?
|
Coronary Thrombosis | 1 | 2016 | 440 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2024 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 384 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2330 | 0.030 |
Why?
|
Adult | 5 | 2023 | 221210 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22173 | 0.020 |
Why?
|
Education | 1 | 2014 | 537 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 709 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8833 | 0.020 |
Why?
|
Middle Aged | 5 | 2023 | 220921 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 39969 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3725 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.020 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1784 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2014 | 2180 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3424 | 0.010 |
Why?
|
Health Surveys | 1 | 2014 | 4061 | 0.010 |
Why?
|
Medication Adherence | 1 | 2014 | 2176 | 0.010 |
Why?
|
Poverty | 1 | 2014 | 2697 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26202 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10212 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2014 | 4028 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18255 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81539 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 88326 | 0.000 |
Why?
|
Animals | 1 | 2014 | 168475 | 0.000 |
Why?
|